Uptake and intracellular activity of voriconazole in human polymorphonuclear leucocytes

被引:15
作者
Ballesta, S [1 ]
García, I [1 ]
Perea, EJ [1 ]
Pascual, A [1 ]
机构
[1] Univ Seville, Sch Med, Dept Microbiol, Seville, Spain
关键词
Candida; azoles; accumulation;
D O I
10.1093/jac/dki075
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: The intracellular penetration of voriconazole into human polymorphonuclear leucocytes (PMNs) and its intracellular activity against Candida spp. were evaluated. Methods: The intracellular penetration of voriconazole into PMNs was evaluated by a radiometric assay. The effect of cell viability, environmental conditions, metabolic inhibitors and membrane stimulation was also studied. The intracellular activity was determined by incubation of PMNs containing intracellular blastospores in the presence of voriconazole for 3 h. Results: The uptake of voriconazole by PMNs was rapid and not saturable. The cellular to extracellular concentration (C/E) ratio for voriconazole was 8.5 +/- 1.3. Voriconazole was rapidly released from loaded PMNs. The uptake of voriconazole was not affected by environmental temperature and cell viability. Neither the external pH nor the metabolic inhibitors affected the uptake of voriconazole. The ingestion of opsonized zymosan, but not of opsonized Candida spp., significantly decreased the levels of PMN-associated voriconazole. At the extracellular concentrations evaluated, voriconazole did not affect the intracellular survival of Candida. Conclusions: Voriconazole reached high intracellular concentrations within human PMNs. The uptake was rapid and not saturable but it did not affect the intracellular killing of Candida spp.
引用
收藏
页码:785 / 787
页数:3
相关论文
共 10 条
[1]   Genetic basis for differential activities of fluconazole and voriconazole against Candida krusei [J].
Fukuoka, T ;
Johnston, DA ;
Winslow, CA ;
de Groot, MJ ;
Burt, C ;
Hitchcock, CA ;
Filler, SG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (04) :1213-1219
[2]   Accumulation and activity of cethromycin (ABT-773) within human polymorphonuclear leucocytes [J].
García, I ;
Pascual, A ;
Ballesta, S ;
del Castillo, C ;
Perea, EJ .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (01) :24-28
[3]  
HERBRECHT R, 2004, EXPERT REV ANTIINFEC, V4, P485
[4]   CLINDAMYCIN UPTAKE BY HUMAN-NEUTROPHILS [J].
KLEMPNER, MS ;
STYRT, B .
JOURNAL OF INFECTIOUS DISEASES, 1981, 144 (05) :472-479
[5]   Evaluation of voriconazole pharmacodynamics using time-kill methodology [J].
Klepser, ME ;
Malone, D ;
Lewis, RE ;
Ernst, EJ ;
Pfaller, MA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (07) :1917-1920
[6]  
Kullberg BJ, 2002, EUR J MED RES, V7, P183
[7]   OUTER MEMBRANE OF SALMONELLA-TYPHIMURIUM TRANSMEMBRANE DIFFUSION OF SOME HYDROPHOBIC SUBSTANCES [J].
NIKAIDO, H .
BIOCHIMICA ET BIOPHYSICA ACTA, 1976, 433 (01) :118-132
[8]   FLUOROMETRIC MEASUREMENT OF OFLOXACIN UPTAKE BY HUMAN POLYMORPHONUCLEAR LEUKOCYTES [J].
PASCUAL, A ;
GARCIA, I ;
PEREA, EJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (05) :653-656
[9]   UPTAKE AND INTRACELLULAR ACTIVITY OF FLUCONAZOLE IN HUMAN POLYMORPHONUCLEAR LEUKOCYTES [J].
PASCUAL, A ;
GARCIA, I ;
CONEJO, C ;
PEREA, EJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (02) :187-190
[10]  
Perea S, 2000, Rev Esp Quimioter, V13, P314